Fujifilm Introduces New Products, Supports Education, & Exhibits Pulmonary Imaging Portfolio at Ats 2018

Allendale, N.J. – May 15, 2018 - FUJIFILM Medical Systems U.S.A., Inc. is exhibiting its portfolio of pulmonary imaging devices at the 114th annual international conference of the American Thoracic Society (ATS) in San Diego, Calif., May 18 – 23. During the conference, Fujifilm will support educational opportunities through its participation in the Clinicians Center workshop. New this year, the company will bring its recently-launched EB-530P Slim Video Bronchoscope and its Radial Probe EBUS System (PB2020-M) to booth 2915, introducing new innovations to over 16,000 healthcare professionals.

“We’re excited to expand our pulmonary portfolio at this year’s ATS. Our Radial Probe EBUS System will allow our providers to have enhanced ultrasonic visualization when performing pulmonary examinations, and the addition of the EB-530P broadens our bronchoscopy product portfolio,” said Keiichi Nagata, president of FUJIFILM Medical Systems U.S.A., Inc.
 
Fujifilm’s Radial Probe EBUS System is designed to provide real-time ultrasound imaging of targeted peripheral lung lesions prior to biopsy. The PB2020-M is a radial ultrasonic transducer that is inserted through the instrument channel of a bronchoscope, localizing the exact position of the lesion.
 
Fujifilm’s EB-530P has a 3.8 mm outer diameter, making it the slimmest bronchoscope in the collection. The Slim Video Bronchoscope has a 1.2 mm instrument channel and features Fujifilm’s proprietary Super CCD Technology.
 
Also available at booth #2915 will be two interactive EBUS stations featuring the Ultrasound Video Bronchoscope (EB-530US), specifically designed for supporting diagnosis and staging and is equipped with a unique 10 degree forward oblique view which allows for optimal maneuverability and visibility. Also included within these two stations will be the SU-1 Ultrasonic Processor. Fujifilm will showcase its high-resolution video bronchoscopes including the EB-530H Standard “Super Image” Video Bronchoscope which has a wide angle image of 140 degrees, 20 degrees wider than the conventional view.
 
On May 21, from 12:50 - 2:00 p.m., Fujifilm will support the Clinicians Center Workshop session titled “Advanced Diagnostic Bronchoscopy.” Fujifilm will provide one EBUS tower of equipment for use in the interactive session, which will highlight the basic principles and innovations of advanced diagnostic bronchoscopy including EBUS and navigational bronchoscopic approaches, tools, and techniques.  


For more information on the technology available at booth #2915, visit FujifilmEndoscopy.com.
 
 
About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com
 
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies.  In the year ended March 31, 2017, the company had global revenues of $20.7 billion, at an exchange rate of 112 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
 

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.